In the race to feed a growing world population effectively as well as develop environmentally sustainable crop protection solutions, messenger RNA technology – the basis for many successful Covid vaccines – looks particularly promising. Applications can eventually extend to biological solutions for other zoonotic diseases, but also chronic and genetic illnesses.
Listen to this podcast with Ulrik Fugmann and Edward Lees, co-heads of our Environmental Strategies Group, and Andrey Zarur, CEO and co-founder of GreenLight Biosciences. They discuss how tailored mRNA molecules can work as safe, effective and specific tools to control pests, while preserving biodiversity and pollinators and keeping large amounts of food from spoiling as a result of fungus infestation (currently, this causes 40% of food waste).
Disclaimer
Companies mentioned herein, are for illustrative purpose only, are not intended as solicitation of the purchase of such securities, and do not constitute any investment advice or recommendation.
Please note that articles may contain technical language. For this reason, they may not be suitable for readers without professional investment experience.
Any views expressed here are those of the author as of the date of publication, are based on available information, and are subject to change without notice. Individual portfolio management teams may hold different views and may take different investment decisions for different clients. This document does not constitute investment advice.
The value of investments and the income they generate may go down as well as up and it is possible that investors will not recover their initial outlay. Past performance is no guarantee for future returns.
Investing in emerging markets, or specialised or restricted sectors is likely to be subject to a higher-than-average volatility due to a high degree of concentration, greater uncertainty because less information is available, there is less liquidity or due to greater sensitivity to changes in market conditions (social, political and economic conditions).
Some emerging markets offer less security than the majority of international developed markets. For this reason, services for portfolio transactions, liquidation and conservation on behalf of funds invested in emerging markets may carry greater risk.
